Product Information
ANTACID EX-STR TABLET CHEW is a generic product labeled by Cardinal Health, priced at $0.0441 per EA under NDC 70000023401. Its NADAC has been published 372 times since Aug 21, 2019.
Strength
160; 105 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000023401
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALUMINUM HYDROXIDE; MAGNESIUM CARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
3/4/2019
Price Statistics
The NADAC for ANTACID EX-STR TABLET CHEW has been published 372 times since Aug 21, 2019, and over the history we have for it it has risen 49.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0441 per EA |
|---|---|
| All-time high | $0.0462 (Jul 15, 2026) |
| All-time low | $0.0295 (Aug 21, 2019) |
| 52-week high | $0.0462 |
| 52-week low | $0.0437 |
| Median price | $0.0362 |
| Average price | $0.0376 |
| Largest weekly change | +20.5% (Feb 22, 2023) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
aluminum hydroxide and magnesium carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANTACID EX-STR TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for ANTACID EX-STR TABLET CHEW, manufactured by Cardinal Health, is $0.0441 per EA (NDC 70000023401), effective Sep 30, 2026.
How has the price of ANTACID EX-STR TABLET CHEW changed over time?
Over the history we have for it, the NADAC for ANTACID EX-STR TABLET CHEW has risen 49.6%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for ANTACID EX-STR TABLET CHEW?
Since Aug 21, 2019, the NADAC for ANTACID EX-STR TABLET CHEW has ranged from a low of $0.0295 (Aug 21, 2019) to a high of $0.0462 (Jul 15, 2026), with a median of $0.0362 per EA.
Are there cheaper alternatives to ANTACID EX-STR TABLET CHEW?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC HEARTBURN ANTACID CHEW TAB, is $0.0376 per EA — about 15% below ANTACID EX-STR TABLET CHEW.
Who manufactures ANTACID EX-STR TABLET CHEW?
ANTACID EX-STR TABLET CHEW (NDC 70000023401) is labeled by Cardinal Health, and CMS classifies it as a generic product.